When Mike launches the PCF, prostate cancer patients and their families face a bleak outlook. More than 200,000 American men will be diagnosed in 1993, and 44,000 will lose their battle that year. Forecasters project the number will rise significantly as the baby boomers age.
Two decades later the actual death rate would be down by more than 50% – and more than 80% below early projections.
PCF changes the way disease research is conducted and becomes a model for many subsequent organizations that adopt its practices.
Its founding principles are as relevant today as they were in 1993: